Shandong Keyuan Pharmaceutical Co. Ltd. A

Price Chart

Risk-Adjusted Performance

Shandong Keyuan Pharmaceutical Co. Ltd. A (301281) Price Performance

Shandong Keyuan Pharmaceutical Co. Ltd. A (301281) trades on SHE in CNY. The company is classified in the Healthcare sector under the Drug Manufacturers - General industry. The stock currently trades at CNY38.24, down 1.47% from the previous close.

Over the past year, 301281 has traded between a low of CNY26.26 and a high of CNY49.61. The stock has gained 26.4% over this period. It is currently 22.9% below its 52-week high.

Shandong Keyuan Pharmaceutical Co. Ltd. A has a market capitalization of $3.69B and a dividend yield of 56.00%.

About Shandong Keyuan Pharmaceutical Co. Ltd. A

Shandong Keyuan Pharmaceutical Co., Ltd. is involved in the research and development, manufacture, and marketing of chemical raw materials and their preparations. It offers gliclazide; metformin hydrochloride; isosorbide mononitrate; isosorbide dinitrate; lansoprazole; mecobalamin; ropivacaine hydrochloride; isoflurane; fluoxetine hydrochloride; clemastine fumarate; chlorpheniramine maleate; esmolol hydrochloride; nicotinamide-tinidazole; amlexanox; nisoldipine; qupibutu; clarithromycin lactobionate; propafenone hydrochloride; potassium diclofenac; chlorzoxazone; esomeprazole sodium; palonosetron hydrochloride; dalafeng; piroxicam; phenylephrine; vildagliptin; parecoxib sodium; ruxolitinib hydrochloride; and lurasidone hydrochloride. The company was founded in 2004 and is headquartered in Jinan, China.

Compare Shandong Keyuan Pharmaceutical Co. Ltd. A

Side-by-side comparison against top Healthcare peers.